Log in to save to my catalogue

Neratinib after trastuzumab-based adjuvant therapy in HER2-positive breast cancer (ExteNET): 5-year...

Neratinib after trastuzumab-based adjuvant therapy in HER2-positive breast cancer (ExteNET): 5-year...

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_journals_1973118212

Neratinib after trastuzumab-based adjuvant therapy in HER2-positive breast cancer (ExteNET): 5-year analysis of a randomised, double-blind, placebo-controlled, phase 3 trial

About this item

Full title

Neratinib after trastuzumab-based adjuvant therapy in HER2-positive breast cancer (ExteNET): 5-year analysis of a randomised, double-blind, placebo-controlled, phase 3 trial

Author / Creator

ExteNET Study Group , Iwata, Hiroji , Chia, Stephen K L , Bashford, Anna , Inoue, Kenichi , Armstrong, Anne C , Wong, Alvin , Buyse, Marc , Harvey, Vernon , Smith, John W. , Konstantinovic, Zora Neskovic , Rodriguez, Gladys I. , Jáñez Martinez, Noelia , Knoop, Ann Soegaard , De Boer, Richard Hendry , Rai, Yoshiaki , Yamamoto, Naohito , Brincat, Stephen , Papish, Steven William , Manalo, Yvonne , Sorensen, Peter Grundtvig , Aogi, Kenjiro , Shimizu, Satoru , Mainwaring, Paul , Chang, Jose , del Barco Berron, Sonia , Dickerson, Laura C. , Klein, Leonard M. , Ruxer, Robert , Veyret, Corinne , Wagnerova, Maria , Richards, Donald A. , Vasileios, Asskikis , Dourthe, Louis Marie , Lu, Yen-Shen , Greenspan, Andrew R. , Gonzalez Santiago, Santiago , Perren, Timothy John , Yau, Chung Cheung Thomas , Pikó, Béla , Sato, Nobuaki , Askoy, Sercan , Altundag, Mustafa Kadri , Saip, Pinar , Bajaj, Rajesh , Vestlev, Peter Michael , Dank, Magdolna , Cinieri, Saverio , Suszko-Kazarnowicz, Malgorzata , Yap, Yoon Sim , Chen, Shin-Cheh , Haley, Barbara Bacsik , Inhorn, Roger C. , Koynova, Tatyana , Schneeweiss, Andreas , Cubedo Cervera, Ricardo , Urruticoechea Ribate, Ander , Schwartz, Garry H. , Mocharnuk, Robert Scott , Alkhouri, Nabiel , Erickson, Nicholette , Traynor, Ann , Volterra, Fabio , Capo, Gerardo , Flaherty, Lawrence E. , Baidas, Said , Lybaert, Willem , Holland, David R. , Gonzalez Jimenez, Sonia , Vanlemmens, Laurence , Ruggeri, Enzo Maria , Desai, Ajit , Nixon, David Allen , O'Brien, Edward , Lanier, Keith S. , Brescia, Frankie Ann , Richard, Vincent , Geldhof, Kurt , Bednarik, Otakar , Schwedler, Kathrin , Fries, Stefan , Klare, Peter , Griesinger, Frank , Trufflandier, Nathalie , Chetiyawardana, Anula D. , Papandreou, Christos , Hornyak, Lajos , Simo, Erzsebet , Im, Seock-Ah , Ruit, Jan B. , Ciltas, Aydin , Benekli, Mustafa , Conkright, William A. , Ottaviano, Yvonne , Delmas, Andrew , Steele, Heather A. , Bova, Abby R. , Shirinian, Mihran , O'Rourke, Timothy J. , Francisco, Michael and Carrillo Flores, Maria Regina

Publisher

England: Elsevier Ltd

Journal title

The lancet oncology, 2017-12, Vol.18 (12), p.1688-1700

Language

English

Formats

Publication information

Publisher

England: Elsevier Ltd

More information

Scope and Contents

Contents

ExteNET showed that 1 year of neratinib, an irreversible pan-HER tyrosine kinase inhibitor, significantly improves 2-year invasive disease-free survival after trastuzumab-based adjuvant therapy in women with HER2-positive breast cancer. We report updated efficacy outcomes from a protocol-defined 5-year follow-up sensitivity analysis and long-term t...

Alternative Titles

Full title

Neratinib after trastuzumab-based adjuvant therapy in HER2-positive breast cancer (ExteNET): 5-year analysis of a randomised, double-blind, placebo-controlled, phase 3 trial

Authors, Artists and Contributors

Author / Creator

ExteNET Study Group
Iwata, Hiroji
Chia, Stephen K L
Bashford, Anna
Inoue, Kenichi
Armstrong, Anne C
Wong, Alvin
Buyse, Marc
Harvey, Vernon
Smith, John W.
Konstantinovic, Zora Neskovic
Rodriguez, Gladys I.
Jáñez Martinez, Noelia
Knoop, Ann Soegaard
De Boer, Richard Hendry
Rai, Yoshiaki
Yamamoto, Naohito
Brincat, Stephen
Papish, Steven William
Manalo, Yvonne
Sorensen, Peter Grundtvig
Aogi, Kenjiro
Shimizu, Satoru
Mainwaring, Paul
Chang, Jose
del Barco Berron, Sonia
Dickerson, Laura C.
Klein, Leonard M.
Ruxer, Robert
Veyret, Corinne
Wagnerova, Maria
Richards, Donald A.
Vasileios, Asskikis
Dourthe, Louis Marie
Lu, Yen-Shen
Greenspan, Andrew R.
Gonzalez Santiago, Santiago
Perren, Timothy John
Yau, Chung Cheung Thomas
Pikó, Béla
Sato, Nobuaki
Askoy, Sercan
Altundag, Mustafa Kadri
Saip, Pinar
Bajaj, Rajesh
Vestlev, Peter Michael
Dank, Magdolna
Cinieri, Saverio
Suszko-Kazarnowicz, Malgorzata
Yap, Yoon Sim
Chen, Shin-Cheh
Haley, Barbara Bacsik
Inhorn, Roger C.
Koynova, Tatyana
Schneeweiss, Andreas
Cubedo Cervera, Ricardo
Urruticoechea Ribate, Ander
Schwartz, Garry H.
Mocharnuk, Robert Scott
Alkhouri, Nabiel
Erickson, Nicholette
Traynor, Ann
Volterra, Fabio
Capo, Gerardo
Flaherty, Lawrence E.
Baidas, Said
Lybaert, Willem
Holland, David R.
Gonzalez Jimenez, Sonia
Vanlemmens, Laurence
Ruggeri, Enzo Maria
Desai, Ajit
Nixon, David Allen
O'Brien, Edward
Lanier, Keith S.
Brescia, Frankie Ann
Richard, Vincent
Geldhof, Kurt
Bednarik, Otakar
Schwedler, Kathrin
Fries, Stefan
Klare, Peter
Griesinger, Frank
Trufflandier, Nathalie
Chetiyawardana, Anula D.
Papandreou, Christos
Hornyak, Lajos
Simo, Erzsebet
Im, Seock-Ah
Ruit, Jan B.
Ciltas, Aydin
Benekli, Mustafa
Conkright, William A.
Ottaviano, Yvonne
Delmas, Andrew
Steele, Heather A.
Bova, Abby R.
Shirinian, Mihran
O'Rourke, Timothy J.
Francisco, Michael
Carrillo Flores, Maria Regina

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_proquest_journals_1973118212

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_journals_1973118212

Other Identifiers

ISSN

1470-2045

E-ISSN

1474-5488

DOI

10.1016/S1470-2045(17)30717-9

How to access this item